{"composite_breakdown_label":"","computation_units":"","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":[],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_title":"Antimikrobianoekiko erresistenteak diren organismo jakin batzuek eragindako odol-uhararen infekzioen ehunekoa","graph_titles":[],"graph_type":"line","indicator_name":"Antimikrobianoekiko erresistenteak diren organismo jakin batzuek eragindako odol-uhararen infekzioen ehunekoa","indicator_number":"3.d.2","national_geographical_coverage":"","page_content":"","permalink":"","precision":[],"progress_status":"notstarted","reporting_status":"notstarted","sort":"","standalone":false,"tags":[],"indicador_disponible":"Euskal AEk ez du estatistika jarraitu eta ofizialik egiten adierazlearen metodologiarekin","definicion":null,"formula":null,"desagregacion":null,"periodicidad":null,"observaciones":null,"justificacion_global":"\nAntimikrobianoekiko erresistentzia (AME) munduko mehatxu bat da osasunerako, bizitzeko baliabideetarako, \nelikadura-segurtasunerako eta Garapen Jasangarriko Helburu askoren lorpenerako. Antibiotikoek, antibiralek, \nparasitoen aurkako eragileek eta antifungikoek gero eta eraginkortasun gutxiago dute, gehiegi edo desegoki \nerabiltzeagatik erresistentzia garatzen delako. Horrez gain, ondorio larriak eragiten dituzte gizakien eta \nanimalien osasunean (lehorrekoa eta uretakoa) eta landareen osasunean, eta inpaktu negatiboak elikagaien \nekoizpenean, ingurumenean eta munduko ekonomian. \n\nBereziki, antimikrobianoekiko erresistentziak eragin negatiboa izango du 3. helburuan zerrendatutako jomuga \nasko lortzeko orduan, patogeno erresistenteek eragindako infekzioetarako tratamendu-aukerak murriztu egingo \nbaitira; 2. helburuko jomugei eragingo die, nekazaritza-produktibitatean ondorioak izanik, kontsumorako \nanimalien ekoizpenean barne; eta 1. helburuko xedeei eragingo die, antimikrobianoekiko erresistentzia handitzeak \nhazkunde ekonomikoaren murrizketa handiak ekarriko baititu, desberdintasun ekonomikoa areagotuko baitu eta \nbeste 24 milioi pertsona muturreko pobreziara eramango baititu 2030erako. \n\n\nIturria: Nazio Batuen Estatistika Sekzioa \n","dato_global":"\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_MRSA&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Metizilinarekiko erresistentea den Staphylococcus aureus-ek eragindako odol-uholdearen infekzioaren ehunekoa, arreta bilatzen duten eta odol-lagina hartu eta aztertzen duten pazienteen artean (%) SH_BLD_MRSA</a> UNSTATS\n\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_ECOLI&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Hirugarren belaunaldiko (adibidez, ESBL-E. coli) zefalosporinekiko erresistentea den Escherichia coli-ren ondoriozko odol-uholdearen infekzio-ehunekoa, arreta bilatzen duten eta odol-lagina hartu eta aztertzen zaien pazienteen artean (%) SH_BLD_ECOLI</a> UNSTATS\n","comparabilidad":null,"indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf\">Metadatuak 3-d-2.pdf</a> (ingelesez bakarrik)","national_data_updated_date":"","national_metadata_updated_date":"2025-06-18","en":{"indicador_disponible":"Euskal AEk ez du estatistika jarraitu eta ofizialik egiten adierazlearen metodologiarekin","definicion":null,"formula":null,"desagregacion":null,"periodicidad":null,"observaciones":null,"justificacion_global":"\nAntimicrobial resistance (AMR) is a global threat to health, livelihoods, \nfood security and the achievement of many of the Sustainable Development \nGoals. Antibiotics, antivirals, antiparasitic agents and antifungals are \nincreasingly ineffective owing to resistance developed through their excessive \nor inappropriate use, with serious consequences for human and animal health \n(terrestrial and aquatic), and plant health, and negative impacts on food production, \nthe environment and the global economy. \n\nIn particular, antimicrobial resistance will negatively impact the achievement \nof many of the targets listed under Goal 3 due to reduced treatment options for \ninfections by resistant pathogens; will impact targets under Goal 2 by impacting \nthe agricultural productivity, including food animal production; and will impact \ntargets in Goal 1 as increased antimicrobial resistance will result in large declines \nin economic growth, increase economic inequality and drive an additional 24 million \npeople into extreme poverty by 2030. \n\nSource: United Nations Statistics Division\n","dato_global":"\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_MRSA&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%) SH_BLD_MRSA</a> UNSTATS\n\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_ECOLI&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%) SH_BLD_ECOLI</a> UNSTATS\n","comparabilidad":null,"indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf\">Metadata 3-d-2.pdf</a>"},"es":{"indicador_disponible":"Euskal AEk ez du estatistika jarraitu eta ofizialik egiten adierazlearen metodologiarekin","definicion":null,"formula":null,"desagregacion":null,"periodicidad":null,"observaciones":null,"justificacion_global":"\nLa resistencia a los antimicrobianos (RAM) es una amenaza mundial para la salud, \nlos medios de vida, la seguridad alimentaria y el logro de muchos de los Objetivos \nde Desarrollo Sostenible. Los antibi\u00f3ticos, antivirales, agentes antiparasitarios \ny antif\u00fangicos son cada vez m\u00e1s ineficaces debido a la resistencia desarrollada \npor su uso excesivo o inadecuado, con graves consecuencias para la salud humana y \nanimal (terrestre y acu\u00e1tica) y la salud de las plantas, e impactos negativos en \nla producci\u00f3n de alimentos, el medio ambiente y la econom\u00eda mundial. \n\nEn particular, la resistencia a los antimicrobianos afectar\u00e1 negativamente \nel logro de muchas de las metas enumeradas en el Objetivo 3 debido a la \nreducci\u00f3n de las opciones de tratamiento para las infecciones por \npat\u00f3genos resistentes; afectar\u00e1 a las metas del Objetivo 2 al afectar \nla productividad agr\u00edcola, incluida la producci\u00f3n de animales destinados \nal consumo; y afectar\u00e1 a las metas del Objetivo 1, ya que el aumento de \nla resistencia a los antimicrobianos dar\u00e1 lugar a grandes disminuciones \ndel crecimiento econ\u00f3mico, aumentar\u00e1 la desigualdad econ\u00f3mica y llevar\u00e1 \na otros 24 millones de personas a la pobreza extrema para 2030. \n\nFuente: Divisi\u00f3n de Estad\u00edsticas de las Naciones Unidas\n","dato_global":"\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_MRSA&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Porcentaje de infecci\u00f3n del torrente sangu\u00edneo debida a Staphylococcus aureus resistente a la meticilina (SARM) entre pacientes que buscan atenci\u00f3n y cuya muestra de sangre se toma y analiza (%) SH_BLD_MRSA</a> UNSTATS\n\n<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.d.2&seriesCode=SH_BLD_ECOLI&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=Total\">Porcentaje de infecci\u00f3n del torrente sangu\u00edneo debido a Escherichia coli resistente a cefalosporinas de tercera generaci\u00f3n (p. ej., ESBL-E. coli) entre pacientes que buscan atenci\u00f3n y cuya muestra de sangre se toma y analiza (%) SH_BLD_ECOLI</a> UNSTATS\n","comparabilidad":null,"indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0d-02.pdf\">Metadatos 3-d-2.pdf</a> (solo en ingl\u00e9s)"},"target_number":"3.d","goal_number":"3","indicator_sort_order":"03-0d-02"}